Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Testing effectiveness (Phase 2)Ended earlyNCT05689021
What this trial is testing

CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 8
Not applicableStudy completedNCT04400656
What this trial is testing

PROState Pathway Embedded Comparative Trial

Who this might be right for
Prostate CancerNon-metastatic Prostate CancerMetastatic Prostate Cancer+3 more
Imperial College London 139
Early research (Phase 1)Study completedNCT00450229
What this trial is testing

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateProstate CancerStage I Prostate Cancer+1 more
National Cancer Institute (NCI) 45
Not applicableLooking for participantsNCT03893929
What this trial is testing

The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 5,000
Very early researchLooking for participantsNCT04857502
What this trial is testing

99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Who this might be right for
Prostate CarcinomaRecurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center 30
Very early researchUnknownNCT04996602
What this trial is testing

Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC

Who this might be right for
Prostate Cancer
Peking Union Medical College Hospital 30
Not applicableLooking for participantsNCT05209243
What this trial is testing

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC

Who this might be right for
Prostate CancerStereotactic Body Radiation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic 266
Early research (Phase 1)Study completedNCT01422850
What this trial is testing

Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

Who this might be right for
Hormone-refractory Prostate Cancer
CytoVac A/S 21
Not applicableStudy completedNCT01614548
What this trial is testing

Management of Prostate Cancer in Central China

Who this might be right for
Prostate Cancer
Zhengzhou University 789
Not applicableStudy completedNCT03851926
What this trial is testing

Hypofractionated Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Consorci Sanitari de Terrassa 300
Not applicableStudy completedNCT03511235
What this trial is testing

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Who this might be right for
Prostate Cancer
Myriad Genetic Laboratories, Inc. 774
Not applicableLooking for participantsNCT05804318
What this trial is testing

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

Who this might be right for
Prostate Cancer
Varian, a Siemens Healthineers Company 132
Testing effectiveness (Phase 2)Study completedNCT00480090
What this trial is testing

A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 10
Testing effectiveness (Phase 2)WithdrawnNCT04483414
What this trial is testing

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Metastatic to Bone
Dana Mathews
Post-approval studies (Phase 4)Looking for participantsNCT07841184
What this trial is testing

Modified Saddle Block vs Spinal Anesthesia for TURP

Who this might be right for
TURP(Transurethral Resection of Prostate)Spinal AnesthesiaSaddle Block Anesthesia+1 more
Pakistan Institute of Medical Sciences 60
Not applicableNot Yet RecruitingNCT07158138
What this trial is testing

A Digitally Distributed Yoga Intervention in Prostate Cancer Rehabilitation : Protocol for a Randomized Controlled Trial

Who this might be right for
Prostate Cancer Patients
Region Örebro County 220
Not applicableStudy completedNCT02079025
What this trial is testing

Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate CancerCancer of the Prostate
Exact Imaging 1,676
Not applicableStudy completedNCT00139191
What this trial is testing

Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00025116
What this trial is testing

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 40
Next Page